Compare HUM & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUM | EW |
|---|---|---|
| Founded | 1961 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.0B | 48.9B |
| IPO Year | 2002 | 1999 |
| Metric | HUM | EW |
|---|---|---|
| Price | $387.77 | $90.91 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 20 | 21 |
| Target Price | ★ $238.65 | $96.37 |
| AVG Volume (30 Days) | 1.1M | ★ 3.5M |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.46% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 9.83 | 1.07 |
| Revenue | ★ $129,664,000,000.00 | $6,067,600,000.00 |
| Revenue This Year | $26.15 | $13.39 |
| Revenue Next Year | $6.07 | $9.81 |
| P/E Ratio | ★ $39.31 | $84.58 |
| Revenue Growth | 10.11 | ★ 11.55 |
| 52 Week Low | $163.11 | $72.30 |
| 52 Week High | $428.88 | $96.29 |
| Indicator | HUM | EW |
|---|---|---|
| Relative Strength Index (RSI) | 51.28 | 53.15 |
| Support Level | $353.38 | $81.19 |
| Resistance Level | $387.17 | $93.91 |
| Average True Range (ATR) | 12.62 | 1.75 |
| MACD | 0.17 | -0.12 |
| Stochastic Oscillator | 69.84 | 42.16 |
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.